Works matching IS 22965270 AND DT 2022 AND VI 45 AND IP 6
Results: 13
Front & Back Matter.
- Published in:
- Oncology Research & Treatment, 2022, v. 45, n. 6, p. 1, doi. 10.1159/000525353
- Publication type:
- Article
NSCLC: RWE-Daten zur Sequenztherapie.
- Published in:
- Oncology Research & Treatment, 2022, v. 45, n. 6, p. 382, doi. 10.1159/000525165
- Publication type:
- Article
Society Bulletins.
- Published in:
- Oncology Research & Treatment, 2022, v. 45, n. 6, p. 391, doi. 10.1159/000525132
- Publication type:
- Article
Bone Infarct-Associated Osteosarcoma: Epidemiologic and Survival Trends.
- Published in:
- Oncology Research & Treatment, 2022, v. 45, n. 6, p. 326, doi. 10.1159/000521986
- By:
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2022, v. 45, n. 6, p. 387, doi. 10.1159/000525161
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2022, v. 45, n. 6, p. 384, doi. 10.1159/000525149
- Publication type:
- Article
Erstlinientherapie nicht-transplantationsfähiger Myelom-Patient*innen mit D-Rd.
- Published in:
- Oncology Research & Treatment, 2022, v. 45, n. 6, p. 380, doi. 10.1159/000525134
- Publication type:
- Article
Inflammatory Myofibroblastic Tumor in the Thyroid Gland: A Retrospective Case Series Study and Literature Review.
- Published in:
- Oncology Research & Treatment, 2022, v. 45, n. 6, p. 353, doi. 10.1159/000524489
- By:
- Publication type:
- Article
Efficacy and Safety of PD-1 Immune Checkpoint Inhibitors in Locally Advanced and Advanced Non-Small-Cell Lung Cancer Patients with Chronic Infection.
- Published in:
- Oncology Research & Treatment, 2022, v. 45, n. 6, p. 366, doi. 10.1159/000523854
- By:
- Publication type:
- Article
A Panel of Three Serum MicroRNAs as a Potential Diagnostic Biomarker for Urothelial Carcinoma.
- Published in:
- Oncology Research & Treatment, 2022, v. 45, n. 6, p. 344, doi. 10.1159/000523853
- By:
- Publication type:
- Article
Programmed Cell Death Protein 1 Blockade Elicits Ongoing Remission in 2 Cases of Refractory Epstein-Barr Virus-Associated Metastatic Gastric Carcinoma.
- Published in:
- Oncology Research & Treatment, 2022, v. 45, n. 6, p. 375, doi. 10.1159/000523754
- By:
- Publication type:
- Article
Transparency on Platelet Transfusion in Routine Cancer Care: The Key for Optimal Blood Usage?
- Published in:
- Oncology Research & Treatment, 2022, v. 45, n. 6, p. 336, doi. 10.1159/000522659
- By:
- Publication type:
- Article
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial.
- Published in:
- Oncology Research & Treatment, 2022, v. 45, n. 6, p. 319, doi. 10.1159/000521415
- By:
- Publication type:
- Article